Answers are grounded in this paper and cite their sources.
Key Clinical Message Clonazepam has some evidence in the treatment of tardive dyskinesia. It can be used as an alternative treatment option in situations where vesicular monoamine transporter 2 inhibitors are not available or when it is not feasible to use them.
No takes yet. Share an insight, caveat, or question.
Chhetri et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: